Dideoxynucleosides
 
																	
																		 
																	
																		
																	 
																	
																		 
																	
																		
																	 
																	
																			
																					
	"Dideoxynucleosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
 
	
	
		
			
			
				Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription.
    
			 
			
				
				
					
						| Descriptor ID | 
										
							D015224
						 | 			
					 
					
						| MeSH Number(s) | 
						
							 D13.570.230.500 
						 | 
					 
					
						| Concept/Terms | 
						
							
						 | 
					 
					
				 
			 
			
				Below are MeSH descriptors whose meaning is more general than "Dideoxynucleosides". 
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Dideoxynucleosides". 
				
			 
		 
	 
 
																				
																					
	
	
		
			
			
					
				This graph shows the total number of publications written about "Dideoxynucleosides" by people in this website by year, and whether "Dideoxynucleosides" was a major or minor topic of these publications.  
				
					 
                    To see the data from this visualization as text,  click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
 | 1995 | 1 | 0 | 1 |  | 2001 | 1 | 0 | 1 |  | 2002 | 0 | 1 | 1 |  | 2003 | 0 | 2 | 2 |  | 2004 | 0 | 1 | 1 |  | 2005 | 1 | 1 | 2 |  | 2008 | 1 | 0 | 1 |  | 2013 | 1 | 0 | 1 |  | 2014 | 0 | 1 | 1 |  | 2015 | 0 | 1 | 1 |  | 2016 | 2 | 0 | 2 |  | 2017 | 1 | 0 | 1 |  | 2023 | 0 | 1 | 1 |  | 2025 | 1 | 0 | 1 |  
 
                    To return to the timeline,  click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Dideoxynucleosides" by people in Profiles. 
						
					
								- 
								
Rabie H, Yin DE, Ward S, Rani Y, Ziemba L, Brooks KM, Cressey TR, Masheto GR, Cassim H, Deville JG, Ponatshego PL, Patel F, Aurpibul L, Barnabas SL, Mustich I, Coletti A, Heckman B, Krotje C, Townley E, Moye J, Majji S, Acosta EP, Ryan K, Chandasana H, Brothers CH, Buchanan AM, Flynn PM. Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results. Pediatr Infect Dis J. 2025 May 29; 44(8):777-784. 
															
								 
							
								- 
								
Brooks KM, Kiser JJ, Ziemba L, Ward S, Rani Y, Cressey TR, Masheto GR, Cassim H, Deville JG, Ponatshego PL, Patel F, Aurpibul L, Barnabas SL, Mustich I, Coletti A, Heckman B, Krotje C, Lojacono M, Yin DE, Townley E, Moye J, Majji S, Acosta EP, Ryan K, Chandasana H, Brothers CH, Buchanan AM, Rabie H, Flynn PM. Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study. Lancet HIV. 2023 08; 10(8):e506-e517. 
															
								 
							
								- 
								
Yamada E, Takagi R, Tanabe Y, Fujiwara H, Hasegawa N, Kato S. Plasma and saliva concentrations of abacavir, tenofovir, darunavir, and raltegravir in HIV-1-infected patients?. Int J Clin Pharmacol Ther. 2017 Jul; 55(7):567-570. 
															
								 
							
								- 
								
Magome T, Froelich J, Holtan SG, Takahashi Y, Verneris MR, Brown K, Dusenbery K, Wong J, Hui SK. Whole-Body Distribution of Leukemia and Functional Total Marrow Irradiation Based on FLT-PET and Dual-Energy CT. Mol Imaging. 2017 Jan-Dec; 16:1536012117732203. 
															
								 
							
								- 
								
Hu S, Neff CP, Kumar DM, Habu Y, Akkina SR, Seki T, Akkina R. A humanized mouse model for HIV-2 infection and efficacy testing of a single-pill triple-drug combination anti-retroviral therapy. Virology. 2017 01 15; 501:115-118. 
															
								 
							
								- 
								
Fuchs EJ, Kiser JJ, Hendrix CW, Sulkowski M, Radebaugh C, Bushman L, Ray ML, Andrade A. Plasma and intracellular ribavirin concentrations are not significantly altered by abacavir in hepatitis C virus-infected patients. J Antimicrob Chemother. 2016 06; 71(6):1597-600. 
															
								 
							
								- 
								
Michels AW, Ostrov DA. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity. J Allergy Clin Immunol. 2015 Aug; 136(2):252-7. 
															
								 
							
								- 
								
Yamada E, Takagi R, Sudo K, Kato S. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry. J Pharm Biomed Anal. 2015 Oct 10; 114:390-7. 
															
								 
							
								- 
								
Erlandson KM, Gudza I, Fiorillo S, Ndemera B, Schooley RT, Gwanzura L, Borok M, Campbell TB. Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe. Int J Infect Dis. 2014 Jul; 24:6-10. 
															
								 
							
								- 
								
Wohl DA, Arnoczy G, Fichtenbaum CJ, Campbell T, Taiwo B, Hicks C, McComsey GA, Koletar S, Sax P, Tebas P, Ha B, Massengale K, Walsh K, Stein JH. Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study. Antivir Ther. 2014; 19(2):141-7. 
															
								 
							
				 	
			 	
			
			
		 
	 
 
       
																				
                                                                            
																		
																	 
																 
															 | 
		
																
																	
																		
																			
																					People   People who have written about this concept. _ 
																				
																					
    
        Similar Concepts  
             
        
     
    
        People who have written about this concept.
     
 
_ 
       
																				
																					
    
        Top Journals  
             
        
     
    
        Top journals in which articles about this concept have been published.
     
 
       
																				
																		
																	 
																 
															 |